Home LiteratureArticle Details
PMID: 23318802 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.

Antimicrobial agents and chemotherapy ·Vol. 57 ·No. 4 ·2013-04-00 ·页码 1603-9

De Majumdar S, Veleba M, Finn S, Fanning S, Schneiders T

Abstract

RarA is an AraC-type regulator in Klebsiella pneumoniae, which, when overexpressed, confers a low-level multidrug-resistant (MDR) phenotype linked to the upregulation of both the acrAB and oqxAB efflux genes. Increased rarA expression has also been shown to be integral in the development of tigecycline resistance in the absence of ramA in K. pneumoniae. Given its phenotypic role in MDR, microarray analyses were performed to determine the RarA regulon. Transcriptome analysis was undertaken using strains Ecl8ΔrarA/pACrarA-2 (rarA-expressing construct) and Ecl8ΔrarA/pACYC184 (vector-only control) using bespoke microarray slides consisting of probes derived from the genomic sequences of K. pneumoniae MGH 78578 (NC_009648.1) and Kp342 (NC_011283.1). Our results show that rarA overexpression resulted in the differential expression of 66 genes (42 upregulated and 24 downregulated). Under the COG (clusters of orthologous groups) functional classification, the majority of affected genes belonged to the category of cell envelope biogenesis and posttranslational modification, along with genes encoding the previously uncharacterized transport proteins (e.g., KPN_03141, sdaCB, and leuE) and the porin OmpF. However, genes associated with energy production and conversion and amino acid transport/metabolism (e.g., nuoA, narJ, and proWX) were found to be downregulated. Biolog phenotype analyses demonstrated that rarA overexpression confers enhanced growth of the overexpresser in the presence of several antibiotic classes (i.e., beta-lactams and fluoroquinolones), the antifungal/antiprotozoal compound clioquinol, disinfectants (8-hydroxyquinoline), protein synthesis inhibitors (i.e., minocycline and puromycin), membrane biogenesis agents (polymyxin B and amitriptyline), DNA synthesis (furaltadone), and the cytokinesis inhibitor (sanguinarine). Both our transcriptome and phenotypic microarray data support and extend the role of RarA in the MDR phenotype of K. pneumoniae.

MeSH 主题词
Amaryllidaceae Alkaloids/pharmacology Amitriptyline/pharmacology Anti-Bacterial Agents/pharmacology Bacterial Proteins/genetics,metabolism Drug Resistance, Multiple, Bacterial/genetics Fluoroquinolones/pharmacology Klebsiella pneumoniae/drug effects,genetics,metabolism Microbial Sensitivity Tests Nitrofurans/pharmacology Oxazolidinones/pharmacology Polymyxin B/pharmacology Puromycin/pharmacology Regulon/genetics,physiology
化学物质
Amaryllidaceae Alkaloids Anti-Bacterial Agents Bacterial Proteins Fluoroquinolones Nitrofurans Oxazolidinones Amitriptyline Puromycin furaltadon Polymyxin B sanguinine
作者与单位
共 5 位作者,点击展开单位 / ORCID
De Majumdar Shyamasree
Centre for Infection and Immunity, Queen's University Belfast, Belfast, United Kingdom.
Veleba Mark
Finn Sarah
Fanning Séamus
Schneiders Thamarai
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
1098-6596
Published
2013-04-00
电子出版
2013-00-14
页码
1603-9
Language
English
Country/Region
United States
NLM ID
0315061
基金资助
Medical Research Council · G0601199 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]